Various precursor lesions that are associated with CRC progression via distinct pathways (conventional or serrated), exhibit distinct mucin expression profile [210], which can be used to segregate patients to plan subtype-specific management of CRC. The gene discussed is MUC5AC; the disease is colorectal carcinoma.